These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6446525)

  • 1. Enrichment of suppressor cell activity by hydrocortisone: suppression of in vitro activation of splenocytes from mice bearing Lewis lung carcinoma.
    Clerici E; Schechter B; Feldman M
    Int J Cancer; 1980 Mar; 25(3):349-54. PubMed ID: 6446525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor cells prevent host resistance to tumor growth.
    Schechter B; Feldman M
    Naturwissenschaften; 1979 Mar; 66(3):140-6. PubMed ID: 311899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of mitogen responses and graft-versus-host reaction by splenocytes from mice bearing Lewis lung carcinoma.
    Anaclerio A; Moras ML; Conti G; Mistrello G; Spreafico F
    J Natl Cancer Inst; 1978 Aug; 61(2):471-5. PubMed ID: 28421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autolymphocyte therapy--I. In vivo tumour-specific adoptive cellular therapy of murine melanoma and carcinoma using ex vivo activated memory T-lymphocytes.
    Gold JE; Osband ME
    Eur J Cancer; 1994; 30A(12):1871-82. PubMed ID: 7880620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.
    Young MR; Aquino S; Young ME
    J Leukoc Biol; 1989 Mar; 45(3):262-73. PubMed ID: 2522492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic development of splenic suppressor cells in tumor-bearing mice.
    Kapoor QS
    Immunol Lett; 1981 Nov; 3(5):293-7. PubMed ID: 6459994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing lymphocytes in spleens of tumor-bearing mice: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    Int J Cancer; 1977 Aug; 20(2):239-46. PubMed ID: 892934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
    Kumar V; Caruso T; Bennett M
    J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of polyclonal immunoglobulin biosynthesis by a soluble factor: T-cell dependent and T-cell independent mitogens.
    Krakauer RS; Cathcart MK; Ilfeld DN
    Immunology; 1980 May; 40(1):53-60. PubMed ID: 6448220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice.
    Subiza JL; Viñuela JE; Rodriguez R; Gil J; Figueredo MA; De La Concha EG
    Int J Cancer; 1989 Aug; 44(2):307-14. PubMed ID: 2527208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor cells in mice with murine mammary tumor virus-induced mammary tumors. I. Inhibition of mitogen-induced lymphocyte stimulation.
    Rudczynski AB; Mortensen RF
    J Natl Cancer Inst; 1978 Jan; 60(1):205-11. PubMed ID: 203703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro retrieval of the cytotoxic potential of spleen cells of tumor-bearing mice.
    Schechter B; Feldman M
    Isr J Med Sci; 1978 Jan; 14(1):131-45. PubMed ID: 632079
    [No Abstract]   [Full Text] [Related]  

  • 15. T-cell recruitment from the thymus to the spleen in tumor-bearing mice. II. Functional characteristics of recruited T-cells.
    Tanaka K; Koga Y; Taniguchi K; Kamikaseda K; Nihashi Y; Nomoto K
    J Natl Cancer Inst; 1986 Sep; 77(3):733-8. PubMed ID: 2943928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR; Young ME; Wepsic HT
    Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin modulation of suppressor function in mice and man.
    Serrou B; Rosenfeld C; Caraux J; Thierry C; Cupissol D; Goldstein A
    Ann N Y Acad Sci; 1979; 332():95-100. PubMed ID: 161154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of T-cell mitogen response in Lewis rats: II. Early appearance and loss of suppressor activity.
    Middleton PA; Bullock WW
    Dev Comp Immunol; 1984; 8(4):907-19. PubMed ID: 6240420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor factor secreted by T-lymphocytes from tumor-bearing mice.
    Treves AJ; Cohen IR; Feldman M
    J Natl Cancer Inst; 1976 Aug; 57(2):409-14. PubMed ID: 1087347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.